bpc-157 clinical evidence human trials and the Difference Between an Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded Pentadecapeptide BPC 157, in Clinical

While the causality of auto-Abs and autonomic disorders is not entirely elucidated, and likely varies depending on the infectious disease triggering the production of auto-Abs, one may postulate that removal of these auto-Abs may reduce the risk of autonomic disorder development

This article walks through every piece of available evidence, realistic timelines based on that evidence, and how to evaluate whether AOD-9604 belongs in your protocol

BPC-157 Used to support muscle and tendon recovery, gut health, inflammation reduction, and faster healing

Individuals becoming aware of any potential violations of the CDC COVID-19 Vaccination Program requirements are encouraged to report them to the Office of the Inspector General, U.S